The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.

导出 LinkOut

翻译打印收藏纠错

作者： Núria,Martínez-Cibrián ^[1] ; Valentín,Ortiz-Maldonado ^[1] ; Marta,Español-Rego ^[2] ; Andrea,Blázquez ^[2] ; Joan,Cid ^[3] ; Miquel,Lozano ^[1] ; Laura,Magnano ^[2] ; Eva,Giné ^[4] ; Juan G,Correa ^[5] ; Pablo,Mozas ^[2] ; Luis Gerardo,Rodríguez-Lobato ^[4] ; Andrea,Rivero ^[5] ; Mercedes,Montoro-Lorite ^[1] ; Pilar,Ayora ^[2] ; Sergio,Navarro ^[1] ; Leticia,Alserawan ^[2] ; E Azucena,González-Navarro ^[6] ; Maria,Castellà ^[1] ; María,Sánchez-Castañón ^[1] ; Raquel,Cabezón ^[2] ; Daniel,Benítez-Ribas ^[1] ; Xavier,Setoaín ^[2] ; Sonia,Rodríguez ^[1] ; Helena,Brillembourg ^[2] ; Sara,Varea ^[1] ; Eulalia,Olesti ^[1] ; Elena,Guillén ^[2] ; Joaquín,Sáez-Peñataro ^[3] ; Carlos Fernández,de Larrea ^[3] ; Armando,López-Guillermo ^[3] ; Mariona,Pascal ^[2] ; Álvaro,Urbano-Ispizua ^[3] ; Manel,Juan ^[3] ; Julio,Delgado ^[3]

作者单位： Department of Hematology, Hospital Clínic, Barcelona, Spain. ^[1] Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. ^[2] Department of Immunology, Hospital Clínic, Barcelona, Spain. ^[3] Apheresis Unit, Hospital Clínic, Barcelona, Spain. ^[4] University of Barcelona, Barcelona, Spain. ^[5] CIBERONC, Madrid, Spain. ^[6] Department of Nuclear Medicine, Hospital Clínic, Barcelona, Spain. ^[7] CIBERBBN, Madrid, Spain. ^[8] Department of Radiology, Hospital Clínic, Barcelona, Spain. ^[9] Department of Clinical Pharmacology, Hospital Clínic, Barcelona, Spain. ^[10]

关键词 CAR CD19 NHL var-cel